CompoAtlas

Cortisolv

Natural health product licensed in Canada

Other names
Clear Cortisol, Cortisol R, D-Stress, Relora Calm, Stress
Licence holder
Xymogen
NPN or DIN-HM
80139300
Status
Active licence
Licence date
17 March 2025
Revision date
8 July 2026
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnolia officinalis

Potency : 1.9 % Honokiol

68.75 mgNot calculated
Phellodendron amurense

Source : Phellodendron amurense - Écorce (tige)

Potency : 0.1 % Berberine

22.5 mgNot calculated
L-théanine

Source : L-Théanine

100 mgNot calculated
L-théanine

Source : Camellia sinensis - feuille

100 mgNot calculated
Lagerstroemia speciosa

Source : Lagerstroemia speciosa - feuille

Potency : 1 % Corosolic acid

48 mgNot calculated
Withania somnifera

Source : Withania somnifera - racine

Potency : 0 0.4-1% withanolides

150 mgNot calculated
Withania somnifera

Source : Withania somnifera - racine

Potency : 0.5 % withaferin A

Not specifiedNot calculated

Non-medicinal ingredients

Amidon de maïs modifié, Hypromellose, Cellulose microcristalline, L-Leucine, NA, Amidon prégélatinisé, Palmitate d'ascorbyle, Silice

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Supports healthy cortisol levels, a biomarker of stress. Helps to relieve symptoms of perceived stress. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80139300

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line